15 Tirzepatide (Mounjaro, Zepbound) is a related medication that mimics both GLP-1 and another gut hormone called GIP (glucose-dependent insulinotropic polypeptide), potentially leading to even greater weight loss effects for some individuals
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM
It helps regulate blood sugar, slows digestion, increases feelings of fullness, and signals the brain to reduce appetite
FDA-approved GLP-1/GIP medications for weight loss and type 2 diabetes, including Ozempic, Wegovy, Zepbound, and Mounjaro, may also be eligible for coverage
1) (Pancreas): ,
A study by researchers at the University of Pennsylvania found that people taking GLP-1 medications such as Ozempic, Wegovy, and Mounjaro faced a higher risk of developing alopecia than patients taking two other classes of diabetes drugs